New Stem Cell Method Could Make CAR-T Cancer Therapy More Accessible
Researchers developed a new method to produce cancer-fighting T cells from stem cells on a larger scale.
8/27/2026
Researchers at Boston Medical Center and Boston University developed an efficient method for producing CD4+ helper T cells from induced pluripotent stem cells (iPSCs). These cells help coordinate the immune system and could be used to develop a cancer treatment that can be used for different patients, instead of creating a personalized treatment for each patient. The researchers discovered that controlling a cell signaling pathway helped the stem cells develop into functional immune cells at scale. Their next step is to add cancer-targeting proteins to these cells and test their ability to fight cancer in animals.
My Perspective: I found this fascinating because it could make CAR-T therapy faster and more accessible to patients. I was especially interested in how scientists can use stem cells to produce a large number of immune cells, creating treatments that are ready to use when patients need them.
References
“Scalable Stem Cell Method Advances Off-the-Shelf Car-T Therapies.” Scalable Stem Cell Method Advances Off-the-Shelf CAR-T Therapies, Boston Medical Center, 27 Aug. 2026, www.news-medical.net/news/20260827/Scalable-stem-cell-method-advances-off-the-shelf-CAR-T-therapies.aspx.
Subscribe to our newsletter
Receive weekly updates on recent cord blood banking and stem cell news.